Advertisement
Screener

Acumen Pharmaceuticals, Inc. (ABOS) ROA

Acumen Pharmaceuticals, Inc. (ABOS) ROA

  • 2026-06-30: ROA -90.55%.
  • 2026-03-31: ROA -84.77%.
  • 2025-12-31: ROA -98.78%.
  • 2025-09-30: ROA -93.76%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-90.55%
2026-03-31-84.77%
2025-12-31-98.78%
2025-09-30-93.76%
2025-06-30-79.50%
2025-03-31-56.85%
2024-12-31-42.82%
2024-09-30-30.59%
2024-06-30-22.45%
2024-03-31-18.59%
2023-12-31-16.89%
2023-09-30-17.02%
2023-06-30-26.21%
2023-03-31-23.97%
2022-12-31-21.80%
2022-09-30-18.86%
2022-06-30-14.90%
2022-03-31-37.59%
2021-12-31-43.68%
2021-09-30-39.61%
2021-06-30-125.58%

Annual ROA

DateROA
2025-12-31-98.78%
2024-12-31-42.82%
2023-12-31-16.89%
2022-12-31-21.80%
2021-12-31-43.68%
2020-12-31-16.49%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48